e-space
Manchester Metropolitan University's Research Repository

Chemical Instability and Promiscuity of Arylmethylidenepyrazolinone-Based MDMX Inhibitors.

Stefaniak, Jakub and Lewis, Andrew M and Conole, Daniel and Galan, Sébastien RG and Bataille, Carole JR and Wynne, Graham M and Castaldi, M Paola and Lundbäck, Thomas and Russell, Angela J and Huber, Kilian VM (2018) Chemical Instability and Promiscuity of Arylmethylidenepyrazolinone-Based MDMX Inhibitors. ACS Chemical Biology, 13 (10). pp. 2849-2854. ISSN 1554-8929

[img]
Preview

Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Targeting the protein-protein interaction between p53 and MDM2/MDMX (MDM4) represents an attractive anticancer strategy for the treatment of p53-competent tumors. Several selective and potent MDM2 inhibitors have been developed and entered the clinic; however, the repertoire of MDMX antagonists is still limited. The arylmethylidenepyrazolinone SJ-172550 has been reported as a selective MDMX antagonist; yet, uncertainties about its mechanism of action have raised doubts about its use as a chemical probe. Here, we show that, in addition to its unclear mode of action, SJ-172550 is unstable in aqueous buffers, giving rise to side products of unknown biological activity. Using an SJ-172550-derived affinity probe, we observed promiscuous binding to cellular proteins whereas cellular thermal shift assays did not reveal a stabilizing effect on MDMX. Overall, our results raise further questions about the interpretation of data using SJ-172550 and related compounds to investigate cellular phenotypes.

Impact and Reach

Statistics

Downloads
Activity Overview
87Downloads
128Hits

Additional statistics for this dataset are available via IRStats2.

Altmetric

Actions (login required)

Edit Item Edit Item